Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Integrated Proteins Ltd (519606)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519606 NSE: Trading | Small Cap | Integrated Proteins Share Price
₹13.72 0.65 (4.97%)
As on 13-Nov'26 16:59
Integrated Proteins Ltd (519606)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519606 NSE: Trading | Small Cap | Integrated Proteins Share Price
₹13.72 0.65 (4.97%)
As on 13-Nov'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹245 Cr.
Current Price
₹13.7
52-Week Low / High
₹3 / 16
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
42.5
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-53.77%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹18.7 Cr.
Face Value
₹1
All Time Low / High
₹0.16 / 16.32
Check Before You Invest
Quality
Locked
Login to view analysis.
Valuation
Locked
Login to view analysis.
Price Trend
Locked
Login to view analysis.
Is Integrated Proteins Ltd a good quality company?
Integrated Proteins Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Integrated Proteins Ltd performance compare with that of its Peers?
Revenue growth of Integrated Proteins Ltd vs industry peers?
Integrated Proteins Ltd revenue CAGR is 9.43%, compared to the industry median CAGR of %, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Integrated Proteins Ltd?
Promoters hold 0.00% of the Integrated Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Integrated Proteins Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 51.9% based on the current price.
10 Year X-Ray : Login to view analysis.
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Integrated Proteins Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 3.3% | 2.5% | 0.2% | 0.8% | 1.2% | 2% | 1.6% | 3.9% | 2.4% | 1.3% | - |
| Value Creation Index ⓘ | -0.8 | -0.8 | -1.0 | -1.0 | -0.9 | -0.9 | -0.9 | -0.7 | -0.8 | NA | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.2 | 21.5 | 9.9 | 20 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | 41.2% | 8,858.3% | -53.8% | - |
| Adj EPS ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 |
| YoY Gr. | - | -100% | NA | -100% | NA | 0% | 0% | 0% | 500% | -83.3% | - |
| BVPS (₹) ⓘ | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 1.1 | 1.1 |
| Adj Net Profit ⓘ | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.2 | 1 |
| Cash Flow from Ops. ⓘ | -0.2 | -0.2 | -0.1 | -0.2 | -0.1 | -0.1 | -0.1 | -0.1 | -23.6 | 3.6 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | -0.4 | -0.9 | -1.6 | -0.6 | -0.2 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 288.1% | -53.8% | ||||
| Adj EPS ⓘ | 0% | 0% | 0% | -83.3% | ||||
| BVPSⓘ | 4.6% | 10% | 16.1% | 36.7% | ||||
| Share Price | 51.9% | 83.5% | 116.6% | 258.2% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1.9 | 0.5 | 1 | 0.2 | 0.9 | 1.5 | 1.2 | 1 | 1.7 | 1.1 | 2.7 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | -51.1 | -49.9 | 0.5 | 2.9 | 3.8 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 18.5 | 10.3 | 0.9 | 2.3 | 2.8 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 1.4 | 0 | 0 |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 4,795 | 3,371 | 292 | 970 | 222 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | -100 | -39 | -69 | -115 | 199 |
Valuation of Integrated Proteins - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Annual reports
No annual reports available.
Concalls
No concalls available.
Integrated Proteins Ltd FAQs
The current trading price of Integrated Proteins on 13-Nov-2026 16:59 is ₹13.72.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Nov-2026 the market cap of Integrated Proteins stood at ₹244.6 Cr
The latest P/E ratio of Integrated Proteins as of 12-Nov-2026 is 409.7.
The latest P/B ratio of Integrated Proteins as of 12-Nov-2026 is 11.68.
The 52-week high of Integrated Proteins is ₹16.32 and the 52-week low is ₹2.55.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Integrated Proteins is ₹20.23 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Integrated Proteins Ltd is a below average quality company.
The key valuation ratios of Integrated Proteins Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Integrated Proteins Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Integrated Proteins Ltd
Integrated Proteins Limited was incorporated on October 14, 1992. Since inception, the Company is engaged in processing of various oil seeds like soyabean, mustard/ rapeseed, groundnut, etc. business with wide /various range depending on ultimate application of the products. However, Gujarat enjoys a strong position with regard to availability of groundnut and mustard/rapeseed.
Business area of the company
The company is engaged in the business of Trading in processing of various oil seeds like soyabean, musted/rapeseed, groundnut, etc. business with wide/various range depending on ultimate application of the products. The main object of the company is to cater to the growing industry and offer its products to all the age groups. The company is slowly processing towards becoming a one stop shop for all the retailers.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now